Literature DB >> 35835994

Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice.

Ruiqing Ni1,2,3, Zhenyue Chen1,4, Xosé Luís Deán-Ben1,4, Fabian F Voigt2,5, Daniel Kirschenbaum6, Gloria Shi1, Alessia Villois7, Quanyu Zhou1,4, Alessandro Crimi6, Paolo Arosio7, Roger M Nitsch2,3, K Peter R Nilsson8, Adriano Aguzzi2,6, Fritjof Helmchen2,5, Jan Klohs9,10, Daniel Razansky11,12,13.   

Abstract

Deposits of amyloid-β (Aβ) in the brains of rodents can be analysed by invasive intravital microscopy on a submillimetre scale, or via whole-brain images from modalities lacking the resolution or molecular specificity to accurately characterize Aβ pathologies. Here we show that large-field multifocal illumination fluorescence microscopy and panoramic volumetric multispectral optoacoustic tomography can be combined to longitudinally assess Aβ deposits in transgenic mouse models of Alzheimer's disease. We used fluorescent Aβ-targeted probes (the luminescent conjugated oligothiophene HS-169 and the oxazine-derivative AOI987) to transcranially detect Aβ deposits in the cortex of APP/PS1 and arcAβ mice with single-plaque resolution (8 μm) and across the whole brain (including the hippocampus and the thalamus, which are inaccessible by conventional intravital microscopy) at sub-150 μm resolutions. Two-photon microscopy, light-sheet microscopy and immunohistochemistry of brain-tissue sections confirmed the specificity and regional distributions of the deposits. High-resolution multiscale optical and optoacoustic imaging of Aβ deposits across the entire brain in rodents thus facilitates the in vivo study of Aβ accumulation by brain region and by animal age and strain.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35835994     DOI: 10.1038/s41551-022-00906-1

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   29.234


  86 in total

1.  Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain.

Authors:  William E Klunk; Brian J Lopresti; Milos D Ikonomovic; Iliya M Lefterov; Radosveta P Koldamova; Eric E Abrahamson; Manik L Debnath; Daniel P Holt; Guo-feng Huang; Li Shao; Steven T DeKosky; Julie C Price; Chester A Mathis
Journal:  J Neurosci       Date:  2005-11-16       Impact factor: 6.167

2.  Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer's disease: phase 3 study.

Authors:  Osama Sabri; Marwan N Sabbagh; John Seibyl; Henryk Barthel; Hiroyasu Akatsu; Yasuomi Ouchi; Kohei Senda; Shigeo Murayama; Kenji Ishii; Masaki Takao; Thomas G Beach; Christopher C Rowe; James B Leverenz; Bernardino Ghetti; James W Ironside; Ana M Catafau; Andrew W Stephens; Andre Mueller; Norman Koglin; Anja Hoffmann; Katrin Roth; Cornelia Reininger; Walter J Schulz-Schaeffer
Journal:  Alzheimers Dement       Date:  2015-03-28       Impact factor: 21.566

3.  Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.

Authors:  Craig Curtis; Jose E Gamez; Upinder Singh; Carl H Sadowsky; Teresa Villena; Marwan N Sabbagh; Thomas G Beach; Ranjan Duara; Adam S Fleisher; Kirk A Frey; Zuzana Walker; Arvinder Hunjan; Clive Holmes; Yavir M Escovar; Carla X Vera; Marc E Agronin; Joel Ross; Andrea Bozoki; Mary Akinola; Jiong Shi; Rik Vandenberghe; Milos D Ikonomovic; Paul F Sherwin; Igor D Grachev; Gillian Farrar; Adrian P L Smith; Christopher J Buckley; Richard McLain; Stephen Salloway
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

4.  19F and 1H MRI detection of amyloid beta plaques in vivo.

Authors:  Makoto Higuchi; Nobuhisa Iwata; Yukio Matsuba; Kumi Sato; Kazumi Sasamoto; Takaomi C Saido
Journal:  Nat Neurosci       Date:  2005-03-13       Impact factor: 24.884

Review 5.  Imaging tau and amyloid-β proteinopathies in Alzheimer disease and other conditions.

Authors:  Victor L Villemagne; Vincent Doré; Samantha C Burnham; Colin L Masters; Christopher C Rowe
Journal:  Nat Rev Neurol       Date:  2018-02-16       Impact factor: 42.937

6.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

7.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

8.  Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice.

Authors:  Marc Dhenain; Nadine El Tannir El Tayara; Ting-Di Wu; Maryvonne Guégan; Andreas Volk; Carmen Quintana; Benoît Delatour
Journal:  Neurobiol Aging       Date:  2007-06-27       Impact factor: 4.673

Review 9.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

Review 10.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

View more
  1 in total

1.  Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease.

Authors:  Vasil Kecheliev; Francesco Spinelli; Adrienne Herde; Ahmed Haider; Linjing Mu; Jan Klohs; Simon M Ametamey; Ruiqing Ni
Journal:  Front Aging Neurosci       Date:  2022-09-30       Impact factor: 5.702

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.